Nifty

:

25377.55

Sensex

:

82948.23

-41.00 (-0.16%)
-131.43 (-0.16%)

Login

Nifty
Sensex

:
:

25377.55
82948.23

-41.00 (-0.16%)
-131.43 (-0.16%)

Nectar Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 532649 | NSE: NECLIFE

Watchlist

NSE BSE

31.50

05-Jul-2024

Open
High
Low
Previous Close

31.01
32.39
31.01
30.93

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2473097
785.73
56.50
21.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,043.49
169.87
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,659.22
N/A
0.97

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.24
-6.58
0.30

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.50
-7.16
-0.90

PAT CAGR (%)

10 Years
5 Years
3 Years

-22.77
-30.92
-41.56

P:E (Median)

8 Years
5 Years
3 Years

8.47
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.54
0.50
0.56

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.89
9.02
10.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 359.30 394.12 -8.83% 441.38 388.81 13.52% 452.17 344.13 31.40% 397.96 388.65 2.40%
Expenses 319.50 358.58 -10.90% 392.86 369.04 6.45% 409.98 342.68 19.64% 371.10 396.05 -6.30%
EBITDA 39.80 35.54 11.99% 48.51 19.77 145.37% 42.19 1.44 2,829.86% 26.87 -7.40 -
EBIDTM 9.52% 7.88% 9.45% 4.42% 8.22% 0.37% 5.98% -1.65%
Other Income 0.55 0.47 17.02% 1.47 17.93 -91.80% 0.48 13.24 -96.37% 10.61 10.71 -0.93%
Interest 19.98 17.62 13.39% 24.16 19.66 22.89% 24.84 17.46 42.27% 20.52 20.99 -2.24%
Depreciation 15.46 15.33 0.85% 14.70 14.85 -1.01% 15.37 14.78 3.99% 15.31 14.79 3.52%
PBT 4.92 3.06 60.78% 11.12 3.19 248.59% 2.46 -17.56 - 1.64 -32.47 -
Tax 1.95 1.24 57.26% 10.52 -2.17 - 0.89 -8.27 - 0.63 -10.00 -
PAT 2.97 1.82 63.19% 0.60 5.36 -88.81% 1.56 -9.29 - 1.02 -22.47 -
PATM 0.71% 0.40% 0.12% 1.20% 0.30% -2.40% 0.23% -5.02%
EPS 0.17 0.10 70.00% 0.03 0.30 -90.00% 0.09 -0.52 - 0.06 -1.26 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 359.30 394.12 -8.83% 441.38 388.81 13.52% 452.17 344.13 31.40% 397.96 388.65 2.40%
Expenses 319.50 358.58 -10.90% 392.87 370.73 5.97% 409.98 342.68 19.64% 371.10 396.04 -6.30%
EBITDA 39.80 35.54 11.99% 48.50 18.09 168.10% 42.19 1.45 2,809.66% 26.87 -7.40 -
EBIDTM 9.52% 7.88% 9.45% 4.05% 8.22% 0.37% 5.98% -1.65%
Other Income 0.55 0.47 17.02% 1.47 17.93 -91.80% 0.48 13.24 -96.37% 10.61 10.71 -0.93%
Interest 19.98 17.62 13.39% 24.16 19.66 22.89% 24.84 17.46 42.27% 20.52 20.99 -2.24%
Depreciation 15.46 15.33 0.85% 14.70 14.85 -1.01% 15.37 14.78 3.99% 15.31 14.79 3.52%
PBT 4.92 3.06 60.78% 11.11 1.50 640.67% 2.46 -17.56 - 1.64 -32.47 -
Tax 1.95 1.24 57.26% 10.52 -2.17 - 0.89 -8.27 - 0.63 -10.00 -
PAT 2.97 1.82 63.19% 0.59 3.67 -83.92% 1.56 -9.29 - 1.02 -22.47 -
PATM 0.71% 0.40% 0.12% 0.82% 0.30% -2.40% 0.23% -5.02%
EPS 0.13 0.08 62.50% 0.03 0.16 -81.25% 0.07 -0.41 - 0.05 -1.00 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,650.81 1,684.09 1,523.67 1,668.23 1,541.82 2,362.80 2,784.93 1,875.53 1,643.34 1,676.32 1,643.64 Net Sales Growth 8.91% 10.53% -8.67% 8.20% -34.75% -15.16% 48.49% 14.13% -1.97% 1.99% Cost Of Goods Sold 1,160.42 1,202.24 1,159.20 1,222.29 1,155.62 1,857.58 2,221.15 1,366.48 1,154.17 1,174.68 1,141.33 Gross Profit 490.39 481.85 364.47 445.94 386.21 505.22 563.78 509.05 489.17 501.64 502.31 GP Margin 29.71% 28.61% 23.92% 26.73% 25.05% 21.38% 20.24% 27.14% 29.77% 29.93% 30.56% Total Expenditure 1,493.44 1,532.53 1,468.95 1,509.42 1,440.26 2,144.83 2,521.03 1,639.49 1,419.13 1,437.49 1,376.73 Power & Fuel Cost - 129.52 127.39 101.41 84.63 92.72 103.47 91.85 75.44 87.89 79.60 % Of Sales - 7.69% 8.36% 6.08% 5.49% 3.92% 3.72% 4.90% 4.59% 5.24% 4.84% Employee Cost - 81.71 75.14 71.91 70.55 78.19 76.54 74.65 75.54 78.38 58.93 % Of Sales - 4.85% 4.93% 4.31% 4.58% 3.31% 2.75% 3.98% 4.60% 4.68% 3.59% Manufacturing Exp. - 56.12 45.32 45.56 44.64 46.88 50.38 52.90 53.32 39.56 37.05 % Of Sales - 3.33% 2.97% 2.73% 2.90% 1.98% 1.81% 2.82% 3.24% 2.36% 2.25% General & Admin Exp. - 21.57 19.29 18.32 20.73 19.94 21.77 23.02 20.05 20.34 21.60 % Of Sales - 1.28% 1.27% 1.10% 1.34% 0.84% 0.78% 1.23% 1.22% 1.21% 1.31% Selling & Distn. Exp. - 38.99 41.28 48.03 50.79 45.75 44.68 28.72 39.00 35.24 35.25 % Of Sales - 2.32% 2.71% 2.88% 3.29% 1.94% 1.60% 1.53% 2.37% 2.10% 2.14% Miscellaneous Exp. - 2.37 1.32 1.90 13.31 3.76 3.04 1.87 1.61 1.41 35.25 % Of Sales - 0.14% 0.09% 0.11% 0.86% 0.16% 0.11% 0.10% 0.10% 0.08% 0.18% EBITDA 157.37 151.56 54.72 158.81 101.56 217.97 263.90 236.04 224.21 238.83 266.91 EBITDA Margin 9.53% 9.00% 3.59% 9.52% 6.59% 9.23% 9.48% 12.59% 13.64% 14.25% 16.24% Other Income 13.11 24.33 53.06 11.32 11.38 4.36 6.04 6.04 22.67 5.78 20.00 Interest 89.50 96.89 89.35 78.81 112.03 125.82 148.13 115.20 117.41 123.31 125.59 Depreciation 60.84 60.72 59.12 56.97 60.25 60.77 63.26 64.31 62.25 57.39 76.56 PBT 20.14 18.28 -40.69 34.35 -59.34 35.74 58.55 62.57 67.21 63.91 84.75 Tax 13.99 13.27 -18.24 9.03 -11.50 5.68 11.22 10.41 12.08 9.59 18.49 Tax Rate 69.46% 72.59% 44.83% 26.29% 13.58% 15.89% 19.16% 16.64% 17.97% 15.01% 21.82% PAT 6.15 5.00 -22.46 25.32 -73.15 30.06 47.33 52.15 55.13 54.33 66.26 PAT before Minority Interest 6.15 5.00 -22.46 25.32 -73.15 30.06 47.33 52.15 55.13 54.33 66.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.37% 0.30% -1.47% 1.52% -4.74% 1.27% 1.70% 2.78% 3.35% 3.24% 4.03% PAT Growth 125.02% - - - - -36.49% -9.24% -5.41% 1.47% -18.00% EPS 0.34 0.28 -1.26 1.42 -4.10 1.69 2.65 2.92 3.09 3.05 3.72

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,650.81 1,684.09 1,523.67 1,668.83 1,543.30 2,366.38 2,782.86 1,876.26 1,643.70 1,675.69 1,643.64 Net Sales Growth 8.91% 10.53% -8.70% 8.13% -34.78% -14.97% 48.32% 14.15% -1.91% 1.95% Cost Of Goods Sold 1,160.42 1,202.24 1,159.29 1,223.13 1,157.12 1,858.61 2,217.71 1,367.01 1,154.31 1,174.12 1,141.33 Gross Profit 490.39 481.85 364.38 445.70 386.19 507.77 565.16 509.25 489.39 501.57 502.31 GP Margin 29.71% 28.61% 23.91% 26.71% 25.02% 21.46% 20.31% 27.14% 29.77% 29.93% 30.56% Total Expenditure 1,493.45 1,532.53 1,470.66 1,510.29 1,441.84 2,146.68 2,518.70 1,640.10 1,419.29 1,436.94 1,376.73 Power & Fuel Cost - 129.52 127.39 101.41 84.63 92.72 103.47 91.85 75.44 87.89 79.60 % Of Sales - 7.69% 8.36% 6.08% 5.48% 3.92% 3.72% 4.90% 4.59% 5.25% 4.84% Employee Cost - 81.71 75.14 71.91 70.59 78.19 76.55 74.65 75.54 78.38 58.93 % Of Sales - 4.85% 4.93% 4.31% 4.57% 3.30% 2.75% 3.98% 4.60% 4.68% 3.59% Manufacturing Exp. - 56.12 45.32 45.56 44.64 46.88 50.38 52.90 53.32 39.56 37.05 % Of Sales - 3.33% 2.97% 2.73% 2.89% 1.98% 1.81% 2.82% 3.24% 2.36% 2.25% General & Admin Exp. - 21.58 19.34 18.36 20.74 20.15 21.82 23.02 20.07 20.36 21.60 % Of Sales - 1.28% 1.27% 1.10% 1.34% 0.85% 0.78% 1.23% 1.22% 1.22% 1.31% Selling & Distn. Exp. - 38.99 42.87 48.03 50.82 46.37 45.66 28.72 39.00 35.24 35.25 % Of Sales - 2.32% 2.81% 2.88% 3.29% 1.96% 1.64% 1.53% 2.37% 2.10% 2.14% Miscellaneous Exp. - 2.37 1.32 1.90 13.31 3.76 3.12 1.95 1.61 1.41 35.25 % Of Sales - 0.14% 0.09% 0.11% 0.86% 0.16% 0.11% 0.10% 0.10% 0.08% 0.18% EBITDA 157.36 151.56 53.01 158.54 101.46 219.70 264.16 236.16 224.41 238.75 266.91 EBITDA Margin 9.53% 9.00% 3.48% 9.50% 6.57% 9.28% 9.49% 12.59% 13.65% 14.25% 16.24% Other Income 13.11 24.33 53.06 11.32 11.38 4.36 6.04 6.04 22.67 5.78 20.00 Interest 89.50 96.89 89.36 78.81 112.03 125.83 148.13 115.20 117.41 123.31 125.59 Depreciation 60.84 60.72 59.12 56.97 60.25 60.77 63.26 64.31 62.25 57.39 76.56 PBT 20.13 18.27 -42.42 34.08 -59.45 37.47 58.82 62.68 67.42 63.83 84.75 Tax 13.99 13.27 -18.24 9.03 -11.50 5.68 11.22 10.41 12.08 9.59 18.49 Tax Rate 69.50% 72.63% 43.00% 26.50% 13.57% 15.16% 19.08% 16.61% 17.92% 15.02% 21.82% PAT 6.14 5.00 -24.18 25.05 -73.26 31.79 47.60 52.27 55.34 54.24 66.26 PAT before Minority Interest 6.14 5.00 -24.18 25.05 -73.26 31.79 47.60 52.27 55.34 54.24 66.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.37% 0.30% -1.59% 1.50% -4.75% 1.34% 1.71% 2.79% 3.37% 3.24% 4.03% PAT Growth 123.37% - - - - -33.21% -8.93% -5.55% 2.03% -18.14% EPS 0.34 0.28 -1.36 1.40 -4.11 1.78 2.67 2.93 3.10 3.04 3.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,069.25 1,064.59 1,086.86 1,060.73 1,134.61 1,104.64 1,058.63 1,006.73 954.27 957.95 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 1,046.83 1,042.17 1,064.44 1,038.31 1,112.18 1,082.21 1,036.20 984.30 931.85 935.52 Non-Current Liabilities 141.51 213.12 296.66 126.79 249.67 299.91 355.94 295.66 362.35 396.92 Secured Loans 126.68 213.16 280.80 127.46 120.00 164.40 218.21 161.20 243.44 264.36 Unsecured Loans 13.63 13.31 10.28 0.78 1.48 1.19 1.87 2.60 1.96 1.17 Long Term Provisions 7.94 6.45 6.39 7.74 8.20 9.36 9.07 8.49 6.91 6.01 Current Liabilities 972.82 890.93 1,003.75 1,187.39 1,247.89 1,299.23 1,309.32 1,278.66 1,239.95 1,155.60 Trade Payables 419.66 318.75 376.65 342.15 527.14 483.00 539.42 528.10 496.78 455.58 Other Current Liabilities 138.72 111.40 122.63 131.63 95.44 170.40 123.40 106.88 107.95 90.50 Short Term Borrowings 412.22 458.91 502.77 712.00 619.71 635.97 634.08 630.34 627.24 595.30 Short Term Provisions 2.22 1.86 1.70 1.61 5.59 9.87 12.41 13.34 7.98 14.22 Total Liabilities 2,183.58 2,168.64 2,387.27 2,374.91 2,632.17 2,703.78 2,723.89 2,581.05 2,556.57 2,510.47 Net Block 642.71 661.97 723.10 771.89 784.85 824.82 852.35 881.24 905.58 933.73 Gross Block 1,599.41 1,557.96 1,562.95 1,555.70 1,508.82 1,490.49 1,456.36 1,363.67 1,383.66 1,451.42 Accumulated Depreciation 956.71 895.99 839.85 783.81 723.97 665.68 604.00 482.43 478.08 517.69 Non Current Assets 899.75 937.47 1,033.52 1,137.34 1,018.49 1,036.29 1,063.54 1,085.38 1,092.25 1,105.54 Capital Work in Progress 65.75 77.78 85.10 98.63 115.00 99.55 99.79 102.11 99.35 91.31 Non Current Investment 0.24 0.24 0.57 0.57 0.57 0.60 0.60 0.60 0.60 0.15 Long Term Loans & Adv. 12.62 10.93 9.76 12.17 115.07 108.33 104.19 96.90 82.24 80.34 Other Non Current Assets 178.44 186.54 214.99 254.08 2.99 2.99 6.61 4.53 4.47 0.00 Current Assets 1,283.83 1,231.17 1,353.75 1,237.57 1,613.68 1,667.49 1,660.35 1,495.67 1,464.33 1,369.02 Current Investments 0.50 0.32 0.46 0.46 0.17 0.51 0.51 0.41 0.52 0.44 Inventories 709.15 672.60 659.77 586.97 975.13 914.53 859.43 854.13 836.06 790.98 Sundry Debtors 379.19 279.61 446.98 374.59 396.87 561.38 612.12 500.43 492.24 446.50 Cash & Bank 19.80 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38 Other Current Assets 175.19 96.05 67.05 51.67 220.28 170.50 179.38 127.89 99.09 97.73 Short Term Loans & Adv. 132.88 165.03 161.75 198.45 149.76 98.69 124.56 74.01 67.55 84.61 Net Current Assets 311.01 340.25 350.00 50.17 365.79 368.26 351.03 217.01 224.38 213.42 Total Assets 2,183.58 2,168.64 2,387.27 2,374.91 2,632.17 2,703.78 2,723.89 2,581.05 2,556.58 2,510.47

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,069.25 1,064.59 1,087.90 1,062.03 1,136.13 1,105.16 1,058.66 1,006.68 954.08 957.95 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 1,046.82 1,042.17 1,065.48 1,039.60 1,113.70 1,082.73 1,036.23 984.25 931.65 935.52 Non-Current Liabilities 141.51 213.12 296.29 126.41 249.29 299.92 355.84 295.58 362.30 396.92 Secured Loans 126.68 213.16 280.80 127.46 120.00 164.40 218.21 161.20 243.44 264.36 Unsecured Loans 13.63 13.31 10.28 0.78 1.48 1.19 1.87 2.60 1.96 1.17 Long Term Provisions 7.94 6.45 6.39 7.74 8.20 9.36 9.07 8.49 6.91 6.01 Current Liabilities 972.82 890.93 1,003.83 1,187.39 1,247.89 1,299.91 1,309.32 1,278.66 1,239.95 1,155.60 Trade Payables 419.66 318.75 376.65 342.15 527.14 483.67 539.42 528.10 496.78 455.58 Other Current Liabilities 138.72 111.40 122.71 131.63 95.44 170.40 123.40 106.88 107.95 90.50 Short Term Borrowings 412.22 458.91 502.77 712.00 619.71 635.97 634.08 630.34 627.24 595.30 Short Term Provisions 2.22 1.86 1.70 1.61 5.59 9.87 12.41 13.34 7.98 14.22 Total Liabilities 2,183.58 2,168.64 2,388.02 2,375.83 2,633.31 2,704.99 2,723.82 2,580.92 2,556.33 2,510.47 Net Block 642.71 661.97 723.10 771.89 784.85 824.82 852.35 881.24 905.58 933.73 Gross Block 1,599.41 1,557.96 1,562.95 1,555.70 1,508.82 1,490.49 1,456.36 1,363.67 1,383.66 1,451.42 Accumulated Depreciation 956.71 895.99 839.85 783.81 723.97 665.68 604.00 482.43 478.08 517.69 Non Current Assets 899.75 937.46 1,033.18 1,137.01 1,018.15 1,035.96 1,063.21 1,085.05 1,091.92 1,105.54 Capital Work in Progress 65.75 77.78 85.10 98.63 115.00 99.55 99.79 102.11 99.35 91.31 Non Current Investment 0.24 0.24 0.24 0.24 0.24 0.27 0.27 0.27 0.27 0.15 Long Term Loans & Adv. 12.62 10.93 9.76 12.17 115.07 108.33 104.19 96.90 82.24 80.34 Other Non Current Assets 178.44 186.54 214.99 254.08 2.99 2.99 6.61 4.53 4.47 0.00 Current Assets 1,283.83 1,231.18 1,354.85 1,238.83 1,615.16 1,669.03 1,660.61 1,495.86 1,464.42 1,369.02 Current Investments 0.50 0.32 0.46 0.46 0.17 0.51 0.51 0.41 0.52 0.44 Inventories 709.15 672.60 659.86 587.89 977.55 917.97 859.43 854.65 836.71 790.98 Sundry Debtors 379.19 279.61 446.98 374.83 395.87 558.73 611.97 499.73 491.45 446.50 Cash & Bank 19.81 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38 Other Current Assets 175.19 96.05 67.05 51.67 220.28 170.50 179.38 127.89 99.09 97.73 Short Term Loans & Adv. 132.88 165.03 162.69 198.45 149.76 98.69 124.56 74.01 67.55 84.61 Net Current Assets 311.01 340.26 351.02 51.44 367.27 369.13 351.29 217.20 224.47 213.42 Total Assets 2,183.58 2,168.64 2,388.03 2,375.84 2,633.31 2,704.99 2,723.82 2,580.91 2,556.34 2,510.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 224.69 133.37 95.04 21.33 285.65 238.89 65.14 198.62 168.91 144.41 PBT 18.28 -40.69 34.35 -84.65 35.74 58.55 62.57 67.21 64.83 84.75 Adjustment 137.55 97.08 125.44 148.28 187.58 206.90 175.74 158.85 174.16 185.24 Changes in Working Capital 68.87 76.98 -64.75 -38.69 71.65 -13.00 -160.56 -20.26 -61.52 -119.29 Cash after chg. in Working capital 224.69 133.37 95.04 24.94 294.98 252.45 77.75 205.80 177.47 150.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -3.61 -9.33 -13.56 -12.62 -7.17 -8.56 -6.29 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -17.02 52.03 16.64 -28.62 -33.13 -26.13 -29.43 -18.10 -77.21 -59.53 Net Fixed Assets -29.42 12.31 6.28 -30.51 -33.78 -33.89 -90.37 17.23 59.72 -79.32 Net Investments -0.18 0.47 0.00 -0.29 0.37 0.00 -0.10 0.11 -0.53 -0.23 Others 12.58 39.25 10.36 2.18 0.28 7.76 61.04 -35.44 -136.40 20.02 Cash from Financing Activity -205.44 -185.57 -119.38 11.49 -251.87 -201.09 -39.60 -204.12 -88.68 -61.47 Net Cash Inflow / Outflow 2.23 -0.17 -7.70 4.20 0.65 11.67 -3.90 -23.60 3.03 23.40 Opening Cash & Equivalents 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38 9.98 Closing Cash & Equivalent 19.80 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 224.69 133.65 95.00 21.38 284.96 239.24 65.17 198.76 168.82 144.41 PBT 18.27 -42.42 34.08 -84.77 37.47 58.82 62.68 67.42 64.74 84.75 Adjustment 137.55 98.14 125.47 150.40 186.46 207.17 175.82 158.85 174.16 185.24 Changes in Working Capital 68.87 77.93 -64.54 -40.54 70.36 -13.19 -160.72 -20.34 -61.52 -119.29 Cash after chg. in Working capital 224.69 133.65 95.00 25.09 294.29 252.79 77.79 205.93 177.38 150.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -3.71 -9.33 -13.56 -12.62 -7.17 -8.56 -6.29 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -17.02 51.70 16.64 -28.62 -33.13 -26.13 -29.43 -18.10 -76.88 -59.53 Net Fixed Assets -29.42 12.31 6.28 -30.51 -33.78 -33.89 -90.37 17.23 59.72 -79.32 Net Investments -0.18 0.47 0.00 -0.29 0.37 0.00 -0.10 0.11 -0.53 -0.23 Others 12.58 38.92 10.36 2.18 0.28 7.76 61.04 -35.44 -136.07 20.02 Cash from Financing Activity -205.44 -185.58 -119.38 11.49 -251.87 -201.09 -39.60 -204.12 -88.68 -61.47 Net Cash Inflow / Outflow 2.23 -0.23 -7.73 4.25 -0.03 12.02 -3.87 -23.47 3.27 23.40 Opening Cash & Equivalents 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38 9.98 Closing Cash & Equivalent 19.81 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 47.68 47.47 48.46 47.30 50.59 49.26 47.21 44.89 42.55 41.11 ROA 0.23% -0.99% 1.06% -2.92% 1.13% 1.74% 1.97% 2.15% 2.14% 2.70% ROE 0.47% -2.09% 2.36% -6.66% 2.68% 4.38% 5.05% 5.62% 5.79% 7.17% ROCE 6.54% 2.58% 5.79% 1.41% 8.24% 10.28% 9.12% 9.71% 9.95% 11.58% Fixed Asset Turnover 1.22 1.12 1.23 1.15 1.76 2.11 1.48 1.27 1.27 1.25 Receivable days 62.43 75.92 77.89 79.89 66.26 68.75 97.04 103.90 95.54 85.98 Inventory Days 130.94 139.22 118.20 161.77 130.67 103.93 149.46 176.91 165.59 161.85 Payable days 112.09 109.48 107.32 137.28 82.41 68.82 113.92 128.03 119.13 113.39 Cash Conversion Cycle 81.28 105.66 88.77 104.38 114.51 103.87 132.58 152.78 141.99 134.44 Total Debt/Equity 0.59 0.71 0.79 0.85 0.69 0.82 0.90 0.87 1.01 1.00 Interest Cover 1.19 0.54 1.44 0.24 1.28 1.40 1.54 1.57 1.52 1.67

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 47.68 47.47 48.51 47.36 50.66 49.28 47.21 44.89 42.54 41.11 ROA 0.23% -1.06% 1.05% -2.93% 1.19% 1.75% 1.97% 2.15% 2.14% 2.70% ROE 0.47% -2.25% 2.33% -6.67% 2.84% 4.40% 5.06% 5.64% 5.78% 7.17% ROCE 6.54% 2.49% 5.77% 1.41% 8.32% 10.29% 9.13% 9.73% 9.95% 11.58% Fixed Asset Turnover 1.22 1.12 1.23 1.15 1.76 2.11 1.48 1.27 1.26 1.25 Receivable days 62.43 75.92 77.89 79.75 65.92 68.64 96.93 103.72 95.49 85.98 Inventory Days 130.94 139.23 118.26 161.98 130.89 104.21 149.46 176.99 165.71 161.85 Payable days 112.09 109.47 107.25 137.11 82.45 68.84 113.92 128.03 119.13 113.39 Cash Conversion Cycle 81.28 105.68 88.90 104.62 114.37 104.01 132.47 152.69 142.07 134.44 Total Debt/Equity 0.59 0.71 0.79 0.85 0.69 0.82 0.90 0.87 1.01 1.00 Interest Cover 1.19 0.53 1.43 0.24 1.30 1.40 1.54 1.57 1.52 1.67

Top Investors:

isengard direct pe llc

ingain traders, llc

Annual Reports:

News Update:

Nectar Lifesciences - Quarterly Results
14th Aug 2024, 13:26 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback